The government alleges that BioReference submitted claims to federal healthcare programs for blood tests that were not ordered by a patient's provider.
The government alleges that BioReference submitted claims to federal healthcare programs for blood tests that were not ordered by a patient's provider.
NEW YORK – Finish life sciences firm Medix Biochemica said Wednesday that it has acquired German immunoassay developer Candor Bioscience for an undisclosed amount. Medix said the acquisition adds to ...
The QuickFinder COVID-19/Flu Antigen Self-Test and the QuickFinder COVID-19/Flu Antigen Pro Test detect SARS-CoV-2, influenza A, and influenza B in swab specimens and provide results within 15 minutes ...
The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.
NEW YORK – Guardant Health announced Tuesday that its Guardant Reveal liquid biopsy test has received coverage from Medicare administrative contractor Palmetto GBA to monitor colorectal cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback